CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosisAndrew Dunbar, Ronald Hoffman, Dongjoo Kim et al.|Blood|2023Cited by 37
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative NeoplasmsAndrew Dunbar, Ross L. Levine, Robert L. Bowman et al.|Cancer Discovery|2024Cited by 30
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosisAndrew Dunbar, Ronald Hoffman, Dongjoo Kim et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 6
Increased Interleukin-8 (IL8)-CXCR2 Signaling Promotes Progression of Bone Marrow Fibrosis in Myeloproliferative NeoplasmsAndrew Dunbar, Ronald Hoffman, Min Lü et al.|Blood|2020Cited by 5
<i>Jak2V617F</i> Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms (MPNs)Andrew Dunbar, Ross L. Levine, Robert L. Bowman et al.|Blood|2022Cited by 4